Compared to baseline , the administration of 1 g of Glucevia ( ) for 3 weeks resulted in significantly lower incremental glucose area under the curve ( -28.2 % ; p < 0.01 ) , and significantly lower 2 h blood glucose values ( -14 % ; p < 0.01 ) following an oral glucose tolerance test .